Outcomes after Hematopoietic Stem Cell Transplantation for Children with I-Cell Disease
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 01, 2014
- Source ID
- 10.1016/j.bbmt.2014.06.019
Entities
People
- Christopher C. Dvorak
- Emmanuel Katsanis
- Gretchen M. Eames
- Indira Sahdev
- Jeffrey H. Davis
- Jignesh D. Dalal
- Joanne Kurtzberg
- Martin Andreansky
- Mary Eapen
- Paul J. Orchard
- Robert Krance
- Roger H. Giller
- Sara S. Cathey
- Steven M Devine
- Troy C. Lund
- Victor A. Lewis
- Wensheng He
- Weston P. Miller
- William S. Ferguson
Organizations
- ARIAD Pharmaceuticals
- Actinium Pharmaceuticals (United States)
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- GSK
- Health Research
- Incyte
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Roswell Park Comprehensive Cancer Center
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- St. Baldrick's Foundation
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)
- University of Minnesota
- University of Utah